Effectiveness and Safety of Ezetimibe Added to Statin Therapy in Patients with Primary Dyslipidaemia not Achieving the LDL-C Treatment Goal on Statin Monotherapy

Author： González Carlos A.   Rubio-Guerra Alberto F.   Pavía Abel   Redding Francisco J.   Cervantes José L.   Zacarías José L.   Yza Rubén   Carranza Jaime   Fernández Pedro   Morales Enrique   Robles Francisco J.   Leyva José L.   Rodríguez Leticia  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.27, Iss.5, 2007-01, pp. : 333-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ezetimibe has the edge over statin monotherapy

By  

Inpharma, Vol. 1, Iss. 1431, 2004-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Dyslipidaemia in diabetes: combination statin treatment an option

By  

Inpharma, Vol. 1, Iss. 1310, 2001-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia

By Davidson Michael H  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 1, 2002-01 ,pp. : 125-141

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada

By Kohli Michele  

PharmacoEconomics, Vol. 24, Iss. 8, 2006-01 ,pp. : 815-830

Adis International

Access to resources Recommend Favorite

Ezetimibe monotherapy reduces LDL cholesterol in patients with HIV

By  

Inpharma, Vol. 1, Iss. 1661, 2008-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite